retatrutide effects clinical trial safety data Tirzepatide vs. Retatrutide: Key Differences Explained Retatrutide Side Research Retatrutide and LDL Cholesterol: How

doi: 10.2337/dc13-2855 20 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFNauckMAet al

6 Vall dHebron Hospital and Research Institute, Universitat Autonoma de Barcelona, Headache and Neurological Pain Research Group, Barcelona, Spain

The Food and Drug Administration approved Zepbound for use by adults with a body mass index, or BMI, of at least 30 or a BMI of 27 or more if a patient also has another weight-related condition, such as high blood pressure, heart disease or obstructive sleep apnea

This makes it challenging to determine whether joint pain is a medication side effect or related to underlying health conditions